Table 2.

GPs: For patients with or at risk for familial breast cancer. Who do you think should undertake the following tasks?

%
Should be done by…		Myself	A genetic specialist	A breast specialist
(a) Explain the inheritance pattern of familial breast cancer	France	63.6	26.5	9.6
	Germany	30.0	44.8	25.2
	Netherlands	49.7	43.5	6.8
	UK	33.8	60.4	5.8
p values: D-F, ≤.0001; D-NL, ≤.0001; D-UK, ≤.0001; F-NL, ≤.0001; F-UK, ≤.0001; NL-UK, ≤.0001
(b) Inform about breast cancer genetic risks for relatives	France	77.7	14.3	8.0
	Germany	43.9	33.0	23.1
	Netherlands	34.5	52.1	6.1
	UK	25.8	69.8	4.4
p values: D-F, ≤.0001; D-NL, ≤.0001; D-UK, ≤.0001; F-NL, ≤.0001; F-UK, ≤.0001; NL-UK, ≤.0001
(c) Inform about breast cancer genetic testing	France	56.2	29.6	14.2
	Germany	46.6	30.4	23.0
	Netherlands	41.7	54.4	3.9
	UK	41.6	53.6	4.8
p values: D-F, ≤.0001; D-NL, ≤.0001; D-UK, ≤.0001; F-NL, ≤.0001; F-UK, ≤.0001; NL-UK, ≤.583
(d) Disclose the breast cancer genetic test results to the patient	France	23.5	59.3	17.2
	Germany	43.7	32.4	23.9
	Netherlands	11.6	87.3	1.1
	UK	16.9	76.7	6.4
p values: D-F, ≤.0001; D-NL, ≤.0001; D-UK, ≤.0001; F-NL, ≤.0001; F-UK, ≤.0001; NL-UK, ≤.003
(e) Provide support after breast cancer genetic testing	France	86.1	5.8	8.1
	Germany	59.6	14.3	26.1
	Netherlands	66.4	28.2	5.4
	UK	57.2	34.5	8.3
p values: D-F, ≤.0001; D-NL, ≤.0001; D-UK, ≤.0001; F-NL, ≤.0001; F-UK, ≤.0001; NL-UK, ≤.002
(f) Inform about possible management options available after the results of breast cancer genetic testing	France	51.5	19.0	29.5
	Germany	41.4	20.5	38.1
	Netherlands	33.4	37.9	28.7
	UK	18.4	30.9	50.7
p values: D-F, ≤.083; D-NL, ≤.0001; D-UK, ≤.0001; F-NL, ≤.0001; F-UK, ≤.0001; NL-UK, ≤.0001

Sample size: France, n = 275; Germany, n = 450; Netherlands, n = 264; UK, n = 208